| |
|
|
|
| |
Future Pharmaceuticals: Soaring CROs - Where Charles River Is Headed
Future Pharmaceuticals - November 2008
Charles River was recently the subject of four feature articles in the November 2008 issue of Future Pharmaceuticals. The four articles were:
- As the CRO Flies, a question-and-answer session with Charles River Senior Vice President and Chief Marketing Officer Stephanie Wells and Charles River Corporate Executive Vice President and President of Global Preclinical Services Nancy Gillett about the current trend of outsourcing by pharmaceutical and biotechnology companies.
- Future Image, an article co-written by Charles River Corporate Vice President William Barbo and Director of Imaging Services Patrick McConville about the benefits of preclinical imaging for the discovery process and Charles River’s recent expansion into this sector.
- The FDA Navigators, an article written by Charles River Executive Director of Navigator Services Dennis Meyer that discusses why many pharmaceutical sponsors are turning to CROs to help manage the FDA process and pays particular attention to the offerings of Charles River Navigator Services.
- Looking to the East, an article written by Charles River Corporate Vice President and President of Canadian Preclinical Services Chris Perkin that highlights Charles River’s recent expansion into China.
Click here to read each of the full articles.
|
|
future pharmaceuticals, fda navigators, preclinical imaging, CRO, contract research organization, china
Future Pharmaceuticals: Soaring CROs - Where Charles River Is Headed
Charles River is committed to providing customers with exactly what they need to improve and expedite their research and the discovery, development through first-in-human evaluation, and safe manufacture of new therapies.